2012 EDUCATIONAL BOOK - American Society of Clinical Oncology

childhood cancer in families with germline mutations in BRCA2, MMR and
CDKN2A genes. Fam Cancer. 2008;7:331-337.
22. Barnhill RL, Argenyi ZB, From L, et al. Atypical Spitz nevi/tumors:
lack of consensus for diagnosis, discrimination from melanoma, and prediction
of outcome. Hum Pathol. 1999;30:513-520.
23. Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical
variants, ‘Spitzoid melanoma’ and risk assessment. Mod Pathol. 2006;19:S21-
S33 (suppl 2).
24. Bastian BC, Olshen AB, LeBoit PE, et al. Classifying melanocytic
tumors based on DNA copy number changes. Am J Pathol. 2003;163:1765-
1770.
25. Bastian BC, LeBoit PE, Pinkel D. Mutations and copy number increase
of HRAS in Spitz nevi with distinctive histopathological features. Am J
Pathol. 2000;157:967-972.
26. Gill M, Cohen J, Renwick N, et al. Genetic similarities between Spitz
nevus and Spitzoid melanoma in children. Cancer. 2004;101:2636-2640.
27. van Dijk MC, Bernsen MR, Ruiter DJ. Analysis of mutations in B-RAF,
N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and
spitzoid melanoma. Am J Surg Pathol. 2005;29:1145-1151.
28. Maldonado JL, Timmerman L, Fridlyand J, et al. Mechanisms of
cell-cycle arrest in Spitz nevi with constitutive activation of the MAP-kinase
pathway. Am J Pathol. 2004;164:1783-1787.
29. Al Dhaybi R, Agoumi M, Gagné I, et al. P16 expression: a marker of
differentiation between childhood malignant melanomas and Spitz nevi. JAm
Acad Dermatol. 2011;65:357-363.
30. Lee DA, Cohen JA, Twaddell WS, et al. Are all melanomas the same?
592
FARIBA NAVID
Spitzoid melanoma is a distinct subtype of melanoma. Cancer. 2006;106:907-
913.
31. Palmedo G, Hantschke M, Rutten A, et al. The T1796A mutation of the
BRAF gene is absent in Spitz nevi. J Cutan Pathol. 2004;31:266-270.
32. Yazdi AS, Palmedo G, Flaig MJ, et al. Mutations of the BRAF gene in
benign and malignant melanocytic lesions. J Invest Dermatol. 2003;121:1160-
1162.
33. Fullen DR, Poynter JN, Lowe L, et al. BRAF and NRAS mutations in
spitzoid melanocytic lesions. Mod Pathol. 2006;19:1324-1332.
34. Castilla EE, da Graca Dutra M, Orioli-Parreiras IM. Epidemiology of
congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J
Dermatol. 1981;104:307-315.
35. DeDavid M, Orlow SJ, Provost N, et al. A study of large congenital
melanocytic nevi and associated malignant melanomas: review of cases in the
New York University Registry and the world literature. J Am Acad Dermatol.
1997;36:409-416.
36. Bastian BC, Xiong J, Frieden IJ, et al. Genetic changes in neoplasms
arising in congenital melanocytic nevi: differences between nodular proliferations
and melanomas. Am J Pathol. 2002;161:1163-1169.
37. Papp T, Pemsel H, Zimmermann R, et al. Mutational analysis of the
N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic
naevi. J Med Genet. 1999;36:610-614.
38. Bauer J, Curtin JA, Pinkel D, et al. Congenital melanocytic nevi
frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol.
2007;127:179-182.
39. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF
mutations in nevi. Nat Genet. 2003;33:19-20.